Cefimoon-CV 200 Tablet is a combination antibiotic containing Cefixime 200 mg and Potassium Clavulanate 125 mg.
Cefixime is a third-generation cephalosporin antibiotic that inhibits bacterial cell-wall synthesis. Potassium Clavulanate acts as a beta-lactamase inhibitor and can help protect the antibacterial activity of the formulation against certain beta-lactamase-producing bacteria.
The combination may therefore be prescribed for selected bacterial infections where the physician considers this combination appropriate.
Drug Contains:
- Cefixime – 200 mg
- Potassium Clavulanate – 125 mg
Key Features:
- Dual-component antibacterial formulation
- Contains Cefixime and beta-lactamase inhibitor
- Designed for susceptible bacterial infections
- Useful where beta-lactamase-mediated resistance is considered
Pack Size: 6 Tablets
Recommended Use: Only as prescribed by a healthcare professional.
